Wednesday, March 11

Healthcare

Soleno lead asset granted FDA priority review

08/28/20241 Min Read

asset FDA granted lead priority review Soleno

Previous ArticleEnsysce wins $14M federal grant for lead pain therapy

Next Article Eli Lilly Zepbound prices slashed by 50% for lowest doses